-

Dr. Maurice O’Gorman to Speak on AAAS Webinar About Monitoring the Immune System as a Way to Fight COVID-19

original Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET. O’Gorman is Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. (Photo: Business Wire)

Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET. O’Gorman is Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. (Photo: Business Wire)

LOS ANGELES--(BUSINESS WIRE)--Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET.

He will be part of an expert panel of speakers that will also include Andrea Cossarizza, MD, PhD, Vice Dean of the School of Medicine at the University of Modena and Reggio Emilia in Italy, and President of the International Society for Advancement of Cytometry, and Lishomwa Ndhlovu, MBBS, PhD, a Professor of immunology at Weill Cornell Medicine in New York and Principal Investigator of the HIV and Emerging Pathogens Immunopathogenesis Laboratory.

Dr. O’Gorman, Chief of Laboratory Medicine at Children's Hospital Los Angeles and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. During this webinar, Dr. O’Gorman will discuss early results from labs around the world that have begun measuring CD4 and CD8 T-cell levels in peripheral blood as potential biomarkers for the prognosis of patients with COVID-19.

Decreased CD4 and CD8 cells means more severe disease.

Hospitals are observing that patients with severe cases of COVID-19 have significantly lower absolute numbers of CD4 and CD8 T-lymphocytes in their peripheral blood, compared to patients with mild or moderate disease. Low numbers of CD4 cells could potentially impact a patient’s ability to form antibodies against the virus, and low CD8 cells could diminish the patient’s ability to eliminate coronavirus from the body.

Dr. O’Gorman will discuss the potential role for routine measurement of CD4 and CD8 T-cells—a process called immunophenotyping—in hospitalized COVID-19 patients participating in clinical trials. Immunophenotyping may provide a tool for prognostics stratification of disease, and potentially as a way to monitor response to treatment.

Register for this Science/AAAS webinar here: https://www.sciencemag.org/custom-publishing/webinars/monitoring-immune-system-fight-covid-19-cd4-status-lymphopenia-and

Contacts

Contact for interviews with Dr. O’Gorman:
Lorenzo Benet
lbenet@chla.usc.edu
323-251-2847

Industry:

Children’s Hospital Los Angeles

Release Summary
CHLA's Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar.
Release Versions
English

Contacts

Contact for interviews with Dr. O’Gorman:
Lorenzo Benet
lbenet@chla.usc.edu
323-251-2847

More News From Children’s Hospital Los Angeles

Jonathan D. Santoro, MD, Appointed Chief of Neurology and Co-Director of the Neurological Institute at Children’s Hospital Los Angeles

LOS ANGELES--(BUSINESS WIRE)--Jonathan D. Santoro, MD, Appointed Chief of Neurology and Co-Director of the Neurological Institute at Children’s Hospital Los Angeles...

Children’s Hospital Los Angeles Kicks off Annual Valentine’s Day Card Drive on CHLA.org

LOS ANGELES--(BUSINESS WIRE)--The sky is the limit for the annual Children’s Hospital Los Angeles (CHLA) Valentine’s Day card drive, which kicks off today on CHLA.org. Hospital supporters and friends are invited to join the fun by sending space-themed Valentine’s Day cards to CHLA patients. “Exchanging valentines gives kids an opportunity to extend kindness toward others,” says Carol Hamamoto, Director of Child Life, Expressive Arts & Therapies, and Volunteer Resources at Children’s Hospita...

Children’s Hospital Los Angeles Once Again Leads Nation in Pediatric Liver Transplant Outcomes

LOS ANGELES--(BUSINESS WIRE)--Children's Hospital Los Angeles (CHLA) continues to lead the nation in pediatric liver transplant outcomes—achieving the best one- and three-year patient survival rates in the United States for the second-straight year, according to newly released data from the Scientific Registry of Transplant Recipients (SRTR) and the Organ Procurement and Transplantation Network (OPTN). In addition to these best-in-class outcomes, CHLA also remained among the nation’s highest-vo...
Back to Newsroom